Amgen (AMGN) options expected to be active after reporting Repatha data

Amgen (NASDAQ: AMGN) March call option implied volatility is at 90, March weekly is at 41, April is at 26; compared to its 52-week range of 16 to 30 into releasing data for its 27,564-patient Repatha cardiovascular outcomes study,

You May Also Be Interested In

• On Holding AG (ONON) call put ratio 4.5 calls to 1 put with a focus on September 28 and 29 calls
• JD.com (JD) call put ratio 3.7 calls to 1 put into President Donald Trump and Chinese President Xi Jinping's summit
• Quanta Services (PWR) call put ratio 1 call to 6.6 puts with a focus on 1600 contracts of October 530 puts trading